For RIT2, preclinical studies suggest an important role in dopaminergic signaling pathways (eg, requisite for dopamine transporter internalization),62 offering a promising approach aimed at addressing the dysregulation of dopaminergic transmission underlying nicotine dependence,63 in turn offering a novel approach to addressing nicotine dependence.63 Here, RIT2 is linked to nicotine dependence.